Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Heterocyclic adenosine receptor antagonists

US Patent 11718622 · Granted Aug 8, 2023

Estimated economic value: $46,838,000

Assignee

Inventors

View full patent text on Google Patents →